Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
May 2019
• Infectious diseases remain a leading cause of
morbidity and mortality worldwide, with HIV,
tuberculosis and malaria estimated to cause
10% of all deaths each year.
Prions
Where are this micro organisms that
causes infections coming?
• Microorganisms that produce infections (sporadic,
epidemic, endemic)
– Endogenous: commensal\saprophyte
– Exogenous: air, soil, water, food, animals,
humans, vectors
1: Minimo AM et al: Deaths: final data for 2004. Natl Vital Rep Stat 55:1, 2007
2: Lopey et al: Global nad regional burden of diseases and risk factors, 2001: systematic analysis of
population health data. Lancet 367:1747,2006
Infectious new clasification:
Community acquired Nosocomial
infectious infectious
G-neg MDR:
Germs AB susceptable +
non-fermentativi:
G-neg posibil
-piocianic
MDR ± ESBL
MDR-multi drug resistant -acinetobacter
ESBL-extended spectrum beta lactamases
Are all microorganisms
causing diseases?
/Adaptive Immunity
Innate defense mechanism
Anatomical Barriers:
Skin and mucosa- mechanic chemical and biological
protection
Aponevroze, seroase
biological protection chimical mechanical,
Macrophages
Dendritic cells
Natural killer (NK)cells
Inflammatory reaction
(vasodil + aflux de cel sang şi fact umorali)
stimulare monocite\macrophage cu sinteză IL1
Centrii termoreglăriifebră
Măduva hematogenă neutrofilie
Stimulează neutrofile fagocitoza
LB creşte producţia de Ac
LT sinteza de IL2
Fibroblast proliferate fibre de collagen
Ficat sinteza proteinelor de fază acută
Host Non specific response
Phagocitosis
2 types of cells macrophages and neutrophils
stages:
•Chimiotaxis = activates cells to the site of infection(C3a, C5a +
complex C5b, 6,7)
•Opsonize = recognition + Training of pathogen agent for
phagocytosis by docking with IgG, C3b)
need to opsonize: pneumococ, stafilococ auriu
H.influenzae, piocianic, Klebsiella,
do not need to opsonize: BGN, staphylococci alb
•Ingestion = fagozom forming
•Digestion =docking with lysosome + inactivate & intracellular
destruction of the pathogen agent; after destruction PN are destroy
puss, MN are not destroy
Host Non specific response
• Complement
– Protein Complex (C1-9) cascade activation
– Activate C lytic complex C6-C9
• Classical pathway: Ag-Ab bound
• Alternative pathway: non specific, endotoxin (BGN), polizaharid
bacterian (BGP), aggregate by Ig
• Lectin activation pathway: mannose binding lectin->binds
bacterium -> C3b->..
– Activated complement cascade: produces membrane attack
complexes MAC
• Punch holes in the surface of foreign organisms->complex C6-
C9 (Neisseria, BGN)
• Opsonisation invaders by C3b ++phagocytosis
• proinflamator effect <- C3a & C5a
• Modulate LB proliferation
• Increases the activity cytotoxic Ac dependent cells NK
Specific response
Liza celulelor infectate de către
celule T citotoxice
Formare de Ac de către limfocitele B
în cadrul RI umoral T dependent
Host specific response (1)
Humoral Immunity
Globulin (gamaglobuline) recognition and specific react with
Ag
• Produce by Limfocite B; 5 class Ig: M,G, A, D, E
• Duties :
– Antitoxic
– Bactericidal (by C activate – Neisseria, BGN)
– Cellular mediated cytotoxicity, Ab dependent (Ab
recognize Ag from infected cells and bind by NK cell Fc,
producing the infected cell death)
– Opsonis for extracellular multiplying bacteria
– Local defense (IgA): inhibitates bacterial
adherence+neutralisis viruses\toxins
– Neutralizes some extracellular viruses (vermicelli,
rubella)
Host specific response (2)
Cellular Immunity (important for inf due to intracellular growth
microorganisms, mediate by Limfocite T)
• Lymphocyte T
– LT helper (CD4) - amplify RIU\RIC by stimulating the proliferation
LB\LT - limfokinelor
– LT suppressor (CD8) – decreases RIU\RIC
• Citokine-limfokine
– Glycoprotein that permit cooperate\interaction between immunity
cells
• Interferon
– glicoproteine species specific
– Biological activity :
• antiviral
• imunomodulator
• anti-tumoral
– 3 tips:
• alfa IF: produced by monocite
• beta-IF: produced by fibroblaste umane
• gama-IF: produced by LT sensibilizate (LTH1)
Microbial attack celular & humeral mechanism
TNFα
IL1, IL8 IL4
IL6 IL10
IFNγ - IL1ra
IL6
NESPECIFIC DEFENCE
skin / mucosa = barrier mecanic & fizico-chimică
fagocitosis:
neutrofile / macrofage
important rol in inf : Candida, Aspergillus,
Criptococcus, Histoplasma
neutrophil abnormalitis patients -> SFI
CELULAR IMUNITY : most important!
Antiparasits imunitatea
Protozoar
majority infections chronic evolution
Imun response does not permit complete parasite elimination
• Celular Imunity :
Esential for : T. gondii / Leishmania
citotoxicity Ab-dependent: most important mechanism
By eozinofil, presence IgE
Patients with impeard ID celulară (HIV) : frequent inf and
severe with protozoare
• Humoral Imunity: rol modest = Ab low protective rol
Metazoare: important rol celular imunity
Imune deficites
• Humoral Imunity
– Hipo/agamaglobulinemia congenital (infecţii cu bacterii cu multiplicare
extracelulară)
– Deficit de IgA (infecţii respiratorii/digestive repetate)
• Complement impearment (infecţii cu bacterii cu multiplicare
extracelulară, Neisseria C6-9)
• Splenectomia (pneumococ H.influenzae, meningococcal)
• Neutropenia
• Functional granulocite abnormalitis (granulomatoza cronică
familială, deficit de G6PDH)
• LT deficit (infecţii cu germeni cu dezvoltare intracelulară)
– Congenital: sd Di George
– Dobândit: hemopatii maligne, transplante, trat imunosupresoare,
denutriţie, malnutriţie, infecţie HIV
• Other imune deficite :
– Diabetis (afectează chemotactismul, fagocitoza, bactericidia PN)
– Hepatic Chirosis, etilism (pneumococ, infectarea spontană a lichidului
de ascită)
NEWLY IDENTIFIED INFECTIOUS DISEASES AND
PATHOGENS (1)
Year Disease or Pathogen
1993 Hantavirus pulmonary syndrome (Sin Nombre
virus)
1992 Vibrio cholerae O139
1991 Guanarito virus
1989 Hepatitis C
1988 Hepatitis E; human herpesvirus 6
1983 HIV
1982 Escherichia coli O157:H7; Lyme borreliosis;
human T-lymphotropic virus type 2
1980 Human T-lymphotropic virus
Source: Workshop presentation by David Heymann, World Health Organization, 1999
NEWLY IDENTIFIED INFECTIOUS DISEASES AND
PATHOGENS (2)
Year Disease or Pathogen
2012 MERS-CoV
2009 H1N1
2004 Avian influenza (human cases)
2003 SARS
1999 Nipah virus
1997 H5N1 (avian influenza A virus)
1996 New variant Creutzfelt-Jacob disease;
Australian bat lyssavirus
1995 Human herpesvirus 8 (Kaposi’s sarcoma virus)
1994 Savia virus; Hendra virus